HRP20190278T1 - Dijagnostički postupci za glaukom - Google Patents

Dijagnostički postupci za glaukom

Info

Publication number
HRP20190278T1
HRP20190278T1 HRP20190278TT HRP20190278T HRP20190278T1 HR P20190278 T1 HRP20190278 T1 HR P20190278T1 HR P20190278T T HRP20190278T T HR P20190278TT HR P20190278 T HRP20190278 T HR P20190278T HR P20190278 T1 HRP20190278 T1 HR P20190278T1
Authority
HR
Croatia
Prior art keywords
glaucoma
diagnostic methods
diagnostic
methods
Prior art date
Application number
HRP20190278TT
Other languages
English (en)
Croatian (hr)
Inventor
Franz Grus
Nils Boehm
Norbert Pfeiffer
Katharina Bell
Original Assignee
M-Lab Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M-Lab Gmbh filed Critical M-Lab Gmbh
Publication of HRP20190278T1 publication Critical patent/HRP20190278T1/hr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/168—Glaucoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rehabilitation Therapy (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20190278TT 2010-04-13 2011-04-13 Dijagnostički postupci za glaukom HRP20190278T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34236310P 2010-04-13 2010-04-13
EP11714916.1A EP2558862B1 (en) 2010-04-13 2011-04-13 Diagnostic methods for glaucoma
PCT/CH2011/000077 WO2011127616A1 (en) 2010-04-13 2011-04-13 Diagnostic methods for glaucoma

Publications (1)

Publication Number Publication Date
HRP20190278T1 true HRP20190278T1 (hr) 2019-04-19

Family

ID=43984128

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20190278TT HRP20190278T1 (hr) 2010-04-13 2011-04-13 Dijagnostički postupci za glaukom

Country Status (17)

Country Link
US (1) US10175251B2 (enExample)
EP (1) EP2558862B1 (enExample)
JP (2) JP2013529292A (enExample)
KR (1) KR101903193B1 (enExample)
CN (1) CN103003693B (enExample)
AU (1) AU2011241402B2 (enExample)
BR (1) BR112012026219B1 (enExample)
CA (1) CA2795270C (enExample)
DK (1) DK2558862T3 (enExample)
ES (1) ES2712060T3 (enExample)
HR (1) HRP20190278T1 (enExample)
HU (1) HUE042703T2 (enExample)
PL (1) PL2558862T3 (enExample)
RU (1) RU2657515C2 (enExample)
TR (1) TR201902542T4 (enExample)
WO (1) WO2011127616A1 (enExample)
ZA (1) ZA201207935B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10842849B2 (en) 2011-02-28 2020-11-24 The Schepens Eye Research Institute, Inc. Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
WO2012118863A1 (en) * 2011-02-28 2012-09-07 The Schepens Eye Research Institute, Inc. Therapies that target autoimmunity for treating glaucoma and optic neuropathy
WO2013126465A1 (en) * 2012-02-21 2013-08-29 MEDEIROS, Felipe, A. Systems and methods for determining retinal ganglion cell populations and associated treatments
ES2759026T3 (es) * 2013-02-26 2020-05-07 Inst Oftalmologico Fernandez Vega S L Método para el diagnóstico de glaucoma basándose en la determinación de niveles de proteínas séricas
US20170224771A1 (en) * 2014-10-15 2017-08-10 Rapid Pathogen Screening, Inc. Histatins as therapeutic agents for ocular surface disease
JP6499918B2 (ja) 2015-05-20 2019-04-10 株式会社トプコン 眼科検査支援システム及び眼科検査支援サーバ
RU2617066C1 (ru) * 2016-04-01 2017-04-19 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ определения показаний к интравитреальному введению цилиарного нейротрофического фактора при лечении заболеваний зрительно-нервного аппарата глаза
US11369695B2 (en) 2016-12-05 2022-06-28 The Jackson Laboratory Fat droplets in retina and optic nerve as a diagnostic marker for neurodegeneration and glaucoma in humans
JP7202609B2 (ja) * 2017-12-13 2023-01-12 国立大学法人東北大学 視神経障害の診断用バイオマーカー
CN108229545B (zh) * 2017-12-22 2021-09-14 北京市商汤科技开发有限公司 青光眼诊断的方法、装置及电子设备
US20220143139A1 (en) * 2019-03-04 2022-05-12 The Schepens Eye Research Institute, Inc. Modulating Neuroinflammation
CN111856037B (zh) * 2020-07-31 2021-06-22 四川大学华西第二医院 Unc45a与hsp10的比值在pop早期预警、诊断、预后评估中的应用和产品
KR102596340B1 (ko) 2020-08-25 2023-11-02 사회복지법인 삼성생명공익재단 안질환 시야 손상 예후 예측 시스템 및 방법과 이를 위한 컴퓨터 프로그램
CN113444789A (zh) * 2021-08-27 2021-09-28 中国医学科学院北京协和医院 青光眼相关生物标志物及其应用
JP2023129215A (ja) * 2022-03-04 2023-09-14 国立大学法人東北大学 緑内障の検出方法
CN114965664A (zh) * 2022-03-21 2022-08-30 上海交通大学 一种获取泪液代谢指纹谱图的方法及筛选方法
CN118425510B (zh) * 2024-05-17 2024-11-19 上海市第一人民医院 一种青光眼诊断的生物标志物及其应用
CN121741201B (zh) * 2026-02-28 2026-07-17 温州医科大学 体液细胞外囊泡膜蛋白在制备诊断青光眼疾病产品中的用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9419267D0 (en) * 1994-09-23 1994-11-09 Unilever Plc Assay devices
RU2187983C2 (ru) 1998-11-10 2002-08-27 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Способ диагностики характера течения глаукомы
US20020102581A1 (en) * 1999-02-19 2002-08-01 Hageman Gregory S. Diagnostics and therapeutics for ocular disorders
US20030149997A1 (en) 1999-02-19 2003-08-07 Hageman Gregory S. Diagnostics and therapeutics for arterial wall disruptive disorders
US7011952B2 (en) * 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
DK1287364T3 (da) 2000-04-29 2009-03-02 Univ Iowa Res Found Diagnostisk og terapi til makulære degenerationsrelaterede lidelser
CN1393470A (zh) * 2001-06-29 2003-01-29 上海博德基因开发有限公司 一种多肽——beta转导素-45.65和编码这种多肽的多核苷酸
AU2002366641A1 (en) * 2001-12-11 2003-06-23 Fibrogen, Inc. Methods for inhibiting ocular processes
EP1551956A4 (en) * 2002-07-12 2006-12-27 Univ Washington METHOD AND SYSTEMS FOR THE EXTENDED IN VITRO CULTURE OF NEURONAL CELLS
EP1552307A1 (en) * 2002-10-18 2005-07-13 Rescom GmbH Diagnosis of glaucoma by complex autoantibody repertoires in body fluids
US7662389B2 (en) * 2003-12-17 2010-02-16 Alcon, Inc. Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
TWI350751B (en) 2003-12-19 2011-10-21 Omega Bio Pharma Ip3 Ltd Pharmaceutical compositions for treating diabetes
CN101267779A (zh) * 2005-07-27 2008-09-17 福罗里达大学研究基金会有限公司 使用热休克治疗眼睛疾病
EP1832600A1 (en) * 2006-03-09 2007-09-12 Max-Delbrück-Centrum Für Molekulare Medizin Peptides against autoantibodies associated with glaucoma and use of these peptides
RU2314535C1 (ru) 2006-07-05 2008-01-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию" Способ диагностики начальной стадии открытоугольной глаукомы
CN101490550A (zh) 2006-07-08 2009-07-22 肯塔基大学研究基金会 肺癌诊断分析
EP1929937A1 (de) 2006-12-07 2008-06-11 F. Hoffmann-Roche AG Vorrichtung und Verfahren zum Untersuchen von Körperflüssigkeiten
RU2371721C2 (ru) 2007-06-25 2009-10-27 Закрытое акционерное общество "Молекулярно-медицинские технологии" Устройство для диагностики с использованием биочипов
GB0724412D0 (en) * 2007-12-14 2008-02-06 Ucl Business Plc Marker
KR101188439B1 (ko) * 2008-04-02 2012-10-08 (주)루미아이제네틱스 녹내장 진단용 키트
EP2354792A1 (en) 2010-02-08 2011-08-10 Biomonitor A/S Method for detecting anti-drug antibodies
KR20100087276A (ko) 2010-07-21 2010-08-04 (주)루미아이제네틱스 녹내장 진단용 키트
KR20100087275A (ko) 2010-07-21 2010-08-04 (주)루미아이제네틱스 녹내장 진단용 키트

Also Published As

Publication number Publication date
PL2558862T3 (pl) 2019-07-31
CA2795270C (en) 2021-06-08
WO2011127616A1 (en) 2011-10-20
US20130172204A1 (en) 2013-07-04
RU2657515C2 (ru) 2018-06-14
KR20130122706A (ko) 2013-11-08
BR112012026219B1 (pt) 2019-12-10
BR112012026219A2 (pt) 2016-07-12
JP2013529292A (ja) 2013-07-18
TR201902542T4 (tr) 2019-03-21
CN103003693A (zh) 2013-03-27
US10175251B2 (en) 2019-01-08
RU2012147551A (ru) 2014-05-20
DK2558862T3 (en) 2019-03-18
AU2011241402A1 (en) 2012-11-15
JP6225157B2 (ja) 2017-11-01
ZA201207935B (en) 2019-07-31
KR101903193B1 (ko) 2018-10-01
AU2011241402B2 (en) 2016-09-15
CN103003693B (zh) 2016-07-06
EP2558862A1 (en) 2013-02-20
CA2795270A1 (en) 2011-10-20
JP2016048265A (ja) 2016-04-07
EP2558862B1 (en) 2018-11-21
HUE042703T2 (hu) 2019-07-29
ES2712060T3 (es) 2019-05-09

Similar Documents

Publication Publication Date Title
ZA201207935B (en) Diagnostic methods for glaucoma
EP2705366A4 (en) DIAGNOSTIC DEVICE
EP2783627A4 (en) DIAGNOSTIC DEVICE
GB201120345D0 (en) Medical console
EP2609848A4 (en) Borescope
EP2716206A4 (en) ENDOSCOPIC DEVICE
EP2764663A4 (en) WIRELESS DIAGNOSTIC SYSTEM
SG11201401212TA (en) Probe unit
EP2668892A4 (en) Borescope
GB201118773D0 (en) Probe
GB201008541D0 (en) Diagnostic methods
ZA201402224B (en) Diagnostic apparatus
GB201012590D0 (en) Methods for diagnosing cancer
GB201116131D0 (en) Probe
EP2664269A4 (en) Borescope
GB201011420D0 (en) Method for diagnosis
EP2533789A4 (en) METHOD FOR IMPROVING THE FUNCTIONALITY OF SPERM
EP2646821A4 (en) NEOANTIC BODY FOR THE DIAGNOSIS OF TISSUE INJURY
GB201016161D0 (en) Diagnostic method
GB201008719D0 (en) Diagnostic method
AP2013007084A0 (en) Diagnostic method
GB201100223D0 (en) Diagnostic method
IL230851A0 (en) diagnostic markers
ZA201301498B (en) Diagnostic method
PL2510866T3 (pl) Endoskop